Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Massimiliano Ammirabile"'
Autor:
Michela Salvatici, Cecilia Caslini, Simona Alesci, Grazia Arosio, Giuliana Meroni, Ferruccio Ceriotti, Massimiliano Ammirabile, Lorenzo Drago
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6781 (2024)
Haemoglobin disorders represent a heterogeneous group of inherited conditions that involve at least one genetic abnormality in one or more of the globin chains, resulting in changes in the structure, function, and/or amount of haemoglobin molecules,
Externí odkaz:
https://doaj.org/article/cc73f8a2f87b478db5e9603a4585260b
Autor:
Marco Alfonso Perrone, Federica Spolaore, Massimiliano Ammirabile, Francesco Romeo, Patrizio Caciagli, Ferruccio Ceriotti, Sergio Bernardini
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 32, Iss , Pp 100715- (2021)
Background: Recent studies have shown that patients diagnosed with coronarivus disease 2019 (COVID-19) and also with previous cardiovascular diseases have a higher mortality due to worsening heart disease. At the same time, patients without previous
Externí odkaz:
https://doaj.org/article/c8f5a00e5a5c44dbbdf06d7a34b22e33
Autor:
Leonilde Pagano, Assunta Viola, Gennaro Fioretti, Massimiliano Ammirabile, Paolo Ricchi, Luciano Prossomariti
Publikováno v:
Haematologica, Vol 92, Iss 7 (2007)
Between January 1995 and December 2005, we conducted a screening program for the presence of Hb Neapolis, a rare abnormal Hb variant, in Campania, a region in Southern Italy. Nineteen patients with Hb Neapolis in heterozygosis and six patients with a
Externí odkaz:
https://doaj.org/article/3b801190546e4ef9b8833ec30d8d7097
Autor:
Daniele Di Luise, Bruno Fattizzo, Stefania Bottalico, Simona Torricelli, Juri Alessandro Giannotta, Maria Laura Chiaretto, Anna Chiara Migliorini, Virna De Zordi, Massimiliano Ammirabile, Ferruccio Ceriotti
Publikováno v:
International journal of laboratory hematologyREFERENCES. 44(1)
Autor:
Aldo Clerico, Alessio Maregnani, Francesco Romeo, Massimiliano Macrini, Massimiliano Ammirabile, Sergio Bernardini, Marco Alfonso Perrone
Publikováno v:
Minerva cardioangiologica. 68(4)
BACKGROUND High sensitivity cardiac troponins I (hs-cTnI) and T (hs-cTnT) and natriuretic peptides (BNP and NT-proBNP) are universally recognized as cardiac reference biomarkers in patients with acute coronary syndromes and heart failure respectively
Autor:
Silvia Costantini, Tiziana Di Matola, Alessia Pepe, Paolo Ricchi, Maria Marsella, Aldo Filosa, Massimiliano Ammirabile
Publikováno v:
Hematology. 23:522-525
Non-transfusion-dependent thalassemia includes a variety of phenotypes and genotypes that rarely require regular transfusions. However, these patients can experience a wide range of complications. The objective of this retrospective study was to veri
Autor:
Aldo Filosa, Patrizia Cinque, Tiziana Di Matola, Massimiliano Ammirabile, Anna Spasiano, Paolo Ricchi, Silvia Costantini
Publikováno v:
Indian J Hematol Blood Transfus
Autor:
Silvia Costantini, Anna Spasiano, Paolo Ricchi, Biagio Gargiulo, Aldo Filosa, Massimiliano Ammirabile, Patrizia Cinque
Publikováno v:
British journal of haematologyReferences. 186(5)
Autor:
Maddalena, Casale, Maria, Marsella, Massimiliano, Ammirabile, Anna, Spasiano, Silvia, Costantini, Patrizia, Cinque, Paolo, Ricchi, Aldo, Filosa
Publikováno v:
Blood transfusion = Trasfusione del sangue. 17(3)
BACKGROUND: Transfusion dependency determines iron overload in thalassaemia major, with devastating complications. Significant liver iron overload has been observed from early childhood and we aimed to evaluate factors that could predict liver iron o
Autor:
Gianfranco De Dominicis, Maria Marsella, Massimiliano Ammirabile, Patrizia Cinque, Tiziana Di Matola, Silvia Costantini, Anna Spasiano, Paolo Ricchi, Aldo Filosa
Publikováno v:
Blood Cells, Molecules, and Diseases. 57:97-99
Patients with Non-Transfusion-Dependent Thalassemia may require regular transfusion therapy. However, these patients are at risk of developing irregular antibodies, making them untransfusable. Second line treatment usually includes hydroxyurea, which